AVDL vs CLOV
Avadel Pharmaceuticals PLC (AVDL) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Avadel Pharmaceuticals PLC (AVDL) is a drug manufacturers - specialty & generic company listed on US.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported AVDL revenue for 2024-12-31 was $169.1M. Net income was -$48.8M. Revenue was up 504.8% from 2023-12-31 to 2024-12-31. AVDL currently screens at market cap $968.5M.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
AVDL currently screens at market cap $968.5M. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the AVDL and CLOV stock pages for the full models.
Not investment advice.